Kexing Biopharm Co Ltd
SSE:688136
Kexing Biopharm Co Ltd
SSE:688136
Price:
32.72
CNY
4.27%
Market Closed
Market Cap:
¥6.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kexing Biopharm Co Ltd
SSE:688136
|
CN |
|
CVW CleanTech Inc
XTSX:CVW
|
CA |
|
Beijing Aosaikang Pharmaceutical Co Ltd
SZSE:002755
|
CN |
|
Loyaltypoint Inc
OTC:LYLP
|
US |
|
Suzhou Huaya Intelligence Technology Co Ltd
SZSE:003043
|
CN |
|
Greenway Technologies Inc
OTC:GWTI
|
US |
|
I
|
Israel Canada TR Ltd
TASE:ISCN
|
IL |
|
HyPower Fuel Inc
OTC:HYPF
|
CA |
|
Olive Tree Estates Ltd
SGX:1H2
|
SG |
|
Z
|
Zhejiang TongLi Transmission Technology Co Ltd
SZSE:301255
|
CN |
|
N
|
Network International Holdings PLC
OTC:NWKLF
|
AE |
|
M
|
M8 Sustainable Ltd
ASX:M8S
|
AU |
|
ITE (Holdings) Ltd
HKEX:8092
|
HK |
|
Investco Corp
OTC:IVCO
|
US |
Multiples-Based Value
The Multiples-Based Value of one
Kexing Biopharm Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 32.72 CNY,
Kexing Biopharm Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Kexing Biopharm Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Kexing Biopharm Co Ltd Competitors
Kexing Biopharm Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Kexing Biopharm Co Ltd
SSE:688136
|
6.5B CNY | 4.8 | 64.8 | 70.3 | 70.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
